OptimizeRx Corp. reported fourth‑quarter 2025 revenue of $32.2 million, essentially flat year‑over‑year, and adjusted EBITDA of $12.0 million, a 20% margin. The company’s earnings per share of $0.26 beat the consensus estimate of $0.23, while revenue surpassed the $31.58 million estimate by roughly $0.6 million.
Full‑year 2025 results showed revenue of $109.4 million, up 19% from $92.1 million in 2024, and adjusted EBITDA of $24.3 million. The combination of a 19% revenue increase and a 20% EBITDA margin gave OptimizeRx its first Rule of 40 rating, a milestone the company has highlighted as a key indicator of profitable growth.
The flat Q4 revenue was offset by a shift toward higher‑margin subscription data services, which now represent a larger share of the company’s top line. Gross margin expanded to 74.8% from 68.1% in the prior year, driven by a favorable solution and channel partner mix. Operating expenses fell by $2.9 million year‑over‑year, a result of post‑acquisition cost reductions and disciplined spending.
Management updated fiscal 2026 guidance to revenue of $109 million to $114 million and adjusted EBITDA of $21 million to $25 million, a downward revision from the previous $118 million to $124 million range. The company cited market volatility, uncertainty surrounding Most Favored Nation (MFN) pricing, and shorter contract durations as reasons for the more conservative outlook.
Investor reaction was muted, with the stock falling 16.5% after the release. The decline was largely driven by the conservative guidance, a drop in net revenue retention from 121% to 116%, and a decrease in average revenue per top‑20 pharma manufacturer from $2,976 to $2,838.
"We delivered a strong fourth quarter, exceeding both consensus and internal expectations, with revenue of $32.2 million and adjusted EBITDA of $12.0 million. For the full year, revenue reached a record $109.4 million and adjusted EBITDA totaled $24.3 million," said CEO Stephen L. Silvestro. "Importantly, one year ago, we set a goal to become a Rule of 40 company and we have, in 2025, achieved this benchmark demonstrating the strength of our profitable growth model and the durability of our platform. We continue to be focused on becoming a sustainable Rule of 40 company over the next few years." Silvestro also noted, "We are beginning to see increased market volatility, driven in part by uncertainty surrounding Most Favored Nation (MFN) pricing. In response, we believe some customers are taking a more measured approach to discretionary spending and contract duration. While this dynamic may create some near‑term headwinds, we continue to see solid engagement across our network and remain confident in the underlying demand trends supporting our business."
"Our business has experienced minimal disruption from AI, and we do not expect to be disrupted in the future...AI may serve as a tailwind."
"Improvements in our product mix and channel partner strategy contributed to higher gross margins in 2025."
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.